研究报告 |
|
|
|
|
耻垢分枝杆菌ClpC和ClpX敲低表达菌株的构建及表型分析* |
白嘉诚1,迟明哲1,胡亚文1,郝梦2,张雪莲1,**() |
1 复旦大学生命科学学院 遗传工程国家重点实验室 上海 200433 2 宁夏回族自治区第四人民医院 银川 750021 |
|
Construction and Biological Characteristics of ClpC and ClpX Knock-down Strains in Mycobacterium smegmatis |
BAI Jia-cheng1,CHI Ming-zhe1,HU Ya-wen1,HAO Meng2,ZHANG Xue-lian1,**() |
1 State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai 200433, China 2 The Fourth Hospital of Ningxia Hui Autonomous Region, Yinchuan 750021, China |
引用本文:
白嘉诚,迟明哲,胡亚文,郝梦,张雪莲. 耻垢分枝杆菌ClpC和ClpX敲低表达菌株的构建及表型分析*[J]. 中国生物工程杂志, 2021, 41(6): 13-22.
BAI Jia-cheng,CHI Ming-zhe,HU Ya-wen,HAO Meng,ZHANG Xue-lian. Construction and Biological Characteristics of ClpC and ClpX Knock-down Strains in Mycobacterium smegmatis. China Biotechnology, 2021, 41(6): 13-22.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2103030
或
https://manu60.magtech.com.cn/biotech/CN/Y2021/V41/I6/13
|
[1] |
World Health Organization. Global tuberculosis report 2020. World Health Organization, 2020. [2021-04-10].https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf.
|
[2] |
Gur E, Biran D, Ron E Z. Regulated proteolysis in Gram-negative bacteria - how and when? Nature Reviews Microbiology, 2011, 9(12):839-848.
doi: 10.1038/nrmicro2669
|
[3] |
Olivares A O, Baker T A, Sauer R T. Mechanistic insights into bacterial AAA plus proteases and protein-remodelling machines. Nature Reviews Microbiology, 2016, 14(1):33-44.
|
[4] |
Gottesman S. Proteases and their targets in Escherichia coli. Annual Review of Genetics, 1996, 30:465-506.
doi: 10.1146/annurev.genet.30.1.465
|
[5] |
Martin A, Baker T A, Sauer R T. Rebuilt AAA + motors reveal operating principles for ATP-fuelled machines. Nature, 2005, 437(7062):1115-1120.
doi: 10.1038/nature04031
|
[6] |
Akopian T, Kandror O, Raju R M, et al. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring. The EMBO Journal, 2012, 31(6):1529-1541.
doi: 10.1038/emboj.2012.5
pmid: 22286948
|
[7] |
Neuwald A F, Aravind L, Spouge J L, et al. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Research, 1999, 9(1):27-43.
|
[8] |
Ribeiro-Guimarães M L, Pessolani M C V. Comparative genomics of mycobacterial proteases. Microbial Pathogenesis, 2007, 43(5-6):173-178.
doi: 10.1016/j.micpath.2007.05.010
|
[9] |
Griffin J E, Gawronski J D, Dejesus M A, et al. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathogens, 2011, 7(9):e1002251. DOI: 10.1371/journal.ppat.1002251.
doi: 10.1371/journal.ppat.1002251
|
[10] |
Sassetti C M, Boyd D H, Rubin E J. Genes required for mycobacterial growth defined by high density mutagenesis. Molecular Microbiology, 2003, 48(1):77-84.
doi: 10.1046/j.1365-2958.2003.03425.x
|
[11] |
Sassetti C M, Rubin E J. Genetic requirements for mycobacterial survival during infection. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(22):12989-12994.
|
[12] |
Schmitt E K, Riwanto M, Sambandamurthy V, et al. The natural product cyclomarin killsMycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. Angewandte Chemie (International Ed in English), 2011, 50(26):5889-5891.
doi: 10.1002/anie.v50.26
|
[13] |
Gao W, Kim J Y, Anderson J R, et al. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrobial Agents and Chemotherapy, 2015, 59(2):880-889.
doi: 10.1128/AAC.04054-14
|
[14] |
Gavrish E, Sit C S, Cao S G, et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills Mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chemistry & Biology, 2014, 21(4):509-518.
doi: 10.1016/j.chembiol.2014.01.014
|
[15] |
Rock J M, Hopkins F F, Chavez A, et al. Programmable transcriptional repression in Mycobacteria using an orthogonal CRISPR interference platform. Nature Microbiology, 2017, 2:16274.
doi: 10.1038/nmicrobiol.2016.274
|
[16] |
Knipfer N, Seth A, Roudiak S G, et al. Species variation in ATP-dependent protein degradation: protease profiles differ between Mycobacteria and protease functions differ between Mycobacterium smegmatis and Escherichia coli. Gene, 1999, 231(1-2):95-104.
pmid: 10231573
|
[17] |
Benaroudj N, Raynal B, Miot M, et al. Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2. BMC Biochemistry, 2011, 12:61.
doi: 10.1186/1471-2091-12-61
pmid: 22132756
|
[18] |
Schmitz K R, Sauer R T. Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase. Molecular Microbiology, 2014, 93(4):617-628.
doi: 10.1111/mmi.12694
pmid: 24976069
|
[19] |
Frees D, Savijoki K, Varmanen P, et al. Clp ATPases and ClpP proteolytic complexes regulate vital biological processes in low GC, Gram-positive bacteria. Molecular Microbiology, 2007, 63(5):1285-1295.
doi: 10.1111/mmi.2007.63.issue-5
|
[20] |
Gur E, Ottofueling R, Dougan D A. Machines of destruction - AAA+ Proteases and the adaptors that control them. Regulated Proteolysis in Microorganisms, 2013, 66:3-33. DOI: 10.1007/978-94-007-5940-4_1.
|
[21] |
Frees D, Gerth U, Ingmer H. Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus. International Journal of Medical Microbiology, 2014, 304(2):142-149.
doi: 10.1016/j.ijmm.2013.11.009
|
[22] |
Raju R M, Unnikrishnan M, Rubin D H F, et al. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection. PLoS Pathogens, 2012, 8(2):e1002511.
doi: 10.1371/journal.ppat.1002511
|
[23] |
DeJesus M A, Gerrick E R, Xu W Z, et al. Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. mBio, 2017, 8(1):e02133-e02116.
|
[24] |
Kansal R G, Gomez-Flores R, Mehta R T. Change in colony morphology influences the virulence as well as the biochemical properties of the Mycobacterium avium complex. Microbial Pathogenesis, 1998, 25(4):203-214.
doi: 10.1006/mpat.1998.0227
|
[25] |
Yamazaki Y, Danelishvili L, Wu M, et al. The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells. Cellular Microbiology, 2006, 8(5):806-814.
doi: 10.1111/cmi.2006.8.issue-5
|
[26] |
Aldridge B B, Fernandez-Suarez M, Heller D, et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science, 2012, 335(6064):100-104.
doi: 10.1126/science.1216166
|
[27] |
Camberg J L, Hoskins J R, Wickner S. ClpXP protease degrades the cytoskeletal protein, FtsZ, and modulates FtsZ polymer dynamics. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(26):10614-10619.
|
[28] |
Sass P, Josten M, Famulla K, et al. Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ. PNAS, 2011, 108(42):17474-17479.
doi: 10.1073/pnas.1110385108
|
[29] |
Silber N, Pan S, Schäkermann S, et al. Cell division protein FtsZ is unfolded for N-terminal degradation by antibiotic-activated ClpP. mBio, 2020, 11(3):e01006-01020. DOI: 10.1128/mbio.01006-20.
|
[30] |
Gopal P, Sarathy J P, Yee M, et al. Pyrazinamide triggers degradation of its target aspartate decarboxylase. Nature Communications, 2020, 11(1):1661.
doi: 10.1038/s41467-020-15516-1
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|